(Total Views: 555)
Posted On: 03/31/2022 10:00:27 PM
Post# of 154138
Just a word of caution…
“ And the FDA already had a therapeutic MAB, Remdesivir, why get another one.”
Remdesivir isn’t a therapeutic monoclonal antibody.
“ Remdesivir, sold under the brand name Veklury,[10][11] is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences.[12] It is administered via injection into a vein.[13][14] During the COVID‑19 pandemic, remdesivir was approved or authorized for emergency use to treat COVID‑19 in numerous countries.[15]”
“ And the FDA already had a therapeutic MAB, Remdesivir, why get another one.”
Remdesivir isn’t a therapeutic monoclonal antibody.
“ Remdesivir, sold under the brand name Veklury,[10][11] is a broad-spectrum antiviral medication developed by the biopharmaceutical company Gilead Sciences.[12] It is administered via injection into a vein.[13][14] During the COVID‑19 pandemic, remdesivir was approved or authorized for emergency use to treat COVID‑19 in numerous countries.[15]”
(0)
(0)
